Form4.ai tracks every SEC insider trade in real time. See every CNSP insider filing with a free account — no card.
See every CNSP insider filing — free account, no card.
Free accountCNS Pharmaceuticals, Inc. (CNSP) has 2 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $10K. Most recent filing: Aug. 18, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Aug 18, 2026 SEC filing | Fisher Michal Director | Bought | $10,000 | +17.2% 90D |
| Aug 18, 2026 SEC filing | Levin Rami CEO and President | Option exercise | — | — |
Create a free account to see all 2 CNSP filings from the last 90 days. No card needed.
Create free accountWant CNSP insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.